Prostaglandin E2 (Synonyms: 前列腺素 E2; PGE2; Dinoprostone)
目录号: PC65631 纯度: ≥98%
CAS No. :363-24-6
商品编号 规格 价格 会员价 是否有货 数量
PC65631-2mg 2mg ¥475.00 请登录
PC65631-5mg 5mg ¥665.00 请登录
PC65631-10mg 10mg ¥1045.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Prostaglandin E2
中文别名
前列腺素;地诺前列酮;前列腺素e;地诺前列酮 API;地诺前列酮 USP标准品;地诺前列酮标准品;(5Z,11Α,13E,15S)-11,15-二羟基-9-酮前列-5,13-二烯-1-酸;7-[3-羟基-2-(3-羟基-1-辛烯基)-5-氧代环戊基]-5-庚烯酸;地诺前列酮 前列腺素 E2;地诺前列酮(前列腺素E2)
英文名称
Prostaglandin E2
英文别名
Prostaglandin E2;(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate;7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid;PGE2;Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)-;Dinoprostone;PGE2 (Prostaglandin E2);Prostaglandin E2 Lipid Maps MS Standard;(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid;Cervidil;Cervidil(R);Cerviprost;l-pge2;MCH (human,mouse,rat);Prepidil;Propess;Prostenon;prostin;prostine2;(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid;(5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;Dinoprostone (prostaglandin E2);Prostin E2;Minprositin E2;Minprostin E2;Dinoproston;(15S)-Prostaglandin E2;Prostarmon E;Dinoprostonum;l-Prostaglandin E2;Dinoprostona;PGE2alpha;Prostaglandin E2alpha;Dinoprostonum [INN-Latin];Dinoprostona [INN-Spanish];Prostaglandin E;(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-hepte
Cas No.
363-24-6
分子式
C20H32O5
分子量
352.47
包装储存
Powder; -20°C; 3 years;In solvent; -80°C; 6 months;
生物活性
Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.
性状
Solid
IC50 & Target[1][2]
Human Endogenous Metabolite
 
体外研究(In Vitro)
PGE2 shows inhibition of IL 2 production in the mixture of irradiated and nonirradiated T lymphocytes. PGE2 (0.1-10 μM) dose-dependently inhibits the production of IL 2. PGE2 acts during the inductive phase of activation of suppressor cells. Preincubation of T lymphocytes with PGE2 induces cells that suppress IL 2 production and PHA proliferation.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
PGE2 (0.3 μg/k, i.p.) significantly reduces the number of peritoneab macrophages undergoing phagocytosis of the methacrybate microbeads in rats. PGE2 (0.1 mg/min, i.a.) increases renal blood flow. PGE2 produces a biphasic change in renal vascular resistance, vasodilatation starts at 0.01 mg/min and is maximal at about 3 mg/min, while at the highest dose used (20 mg/min) PGE2 induces renal vasoconstriction.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years;In solvent; -80°C; 6 months;
ClinicalTrial
结构分类
Ketones, Aldehydes, Acids
溶解度数据
体外研究:
DMSO : 100 mg/mL(283.71 mM;Need ultrasonic)
配制储存液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2